“…Application of the TTC approach has also been proposed for, or extended to, the risk assessment of other types of substances. These include substances present in consumer products (Antignac et al, 2011;Blackburn et al, 2005;SCCS, SCHER and SCENIHR, 2012;SCCS NfG, 2016): micropollutants, drug residues, pesticide metabolites and other impurities in drinking water (Brüschweiler, 2010;EFSA, 2016;Houeto et al, 2012;Laabs et al, 2015;Melching-Kollmuß et al, 2010;Mons et al, 2013); genotoxic impurities in human pharmaceuticals (EMEA, 2006); herbal preparations (EMEA, 2008); homeopathic medicines (Buchholzer et al, 2014); and human pharmaceutical substances carried over in multiproduct manufacturing facilities (Bercu and Dolan, 2013;Stanard et al, 2015). It has also been used as a first-level screening tool to prioritize for review a large number of substances identified as needing an assessment under the Canadian Environmental Protection Act (Health Canada, 2016).…”